Patent Assignment
Reel/Frame 063504/0221
Security Interest
Recorded: 2023-05-01
Pages: 20
Assignor
FIBROGEN, INC.
Executed: 2023-04-29
Assignee
WILMINGTON TRUST, NATIONAL ASSOCIATION
1100 NORTH MARKET STREET, WILMINGTON, DELAWARE, 19890
Covered Properties
(86)
Enhanced Erythropoiesis and Iron Metabolism
Enhanced Erythropoiesis and Iron Metabolism
Pharmaceutical Formulations of a Hif Hydroxylase Inhibitor
Application:
17/198,013 →
Publication:
US 2022/0054474
Methods for Treating Idiopathic Pulmonary Fibrosis
Application:
17/586,620 →
Publication:
US 2022/0151581
Methods for Treatment of Motor Neuron Diseases
Application:
17/688,717 →
Publication:
US 2023/0019602
Methods of Treatment of Muscular Dystrophies
Application:
17/579,581 →
Publication:
US 2022/0144931
Methods of Treating Acute Respiratory Distress Syndrome
Application:
17/217,953 →
Publication:
US 2021/0301006
Compounds, Compositions and Methods for Histone Lysine Demethylase Inhibition
Application:
18/043,117 →
Publication:
US 2024/0002344
Connective Tissue Growth Factor Antibodies
Application:
18/068,977 →
Publication:
US 2024/0076364
Anti-CCR8 Antibodies and Uses Thereof
Application:
63/399,483 →
Modified Anti-Galectin-9 Antibody and Uses Thereof
Application:
63/389,607 →
Modified Anti-Galectin-9 Antibody and Uses Thereof
Application:
63/389,610 →
Methods for Treating Anemia in Subjects Having Kidney Failure Using Inhibitors of Hypoxia-Inducible Factor (Hif) Hydroxylase
Application:
17/394,602 →
Publication:
US 2021/0369702
Treatment of Diabetes
Fat Regulation
Fat Regulation
Enhanced erythropoiesis and iron metabolism
Enhanced Erythropoiesis and Iron Metabolism
Enhanced Erythropoiesis and Iron Metabolism
Enhanced erythropoiesis and iron metabolism
Enhanced Erythropoiesis and Iron Metabolism
Enhanced Erythropoiesis and Iron Metabolism
Enhanced Erythropoiesis and Iron Metabolism
Enhanced Erythropoiesis and Iron Metabolism
Enhanced Erythropoiesis and Iron Metabolism
Enhanced Erythropoiesis and Iron Metabolism
Novel Nitrogen-Containing Heteroaryl Compounds and Methods of Use Thereof
Novel Nitrogen-Containing Heteroaryl Compounds and Methods of Use Thereof
Novel Nitrogen-Containing Heteroaryl Compounds and Methods of Use Thereof
Novel Nitrogen-Containing Heteroaryl Compounds and Methods of Use Thereof
Novel Nitrogen-Containing Heteroaryl Compounds and Methods of Use Thereof
Novel Nitrogen-Containing Heteroaryl Compounds and Methods of Use Thereof
Novel Nitrogen-Containing Heteroaryl Compounds and Methods of Use Thereof
Novel Nitrogen-Containing Heteroaryl Compounds and Methods of Use Thereof
Novel Nitrogen-Containing Heteroaryl Compounds and Methods of Use Thereof
Novel Nitrogen-Containing Heteroaryl Compounds and Methods of Use Thereof
Novel Nitrogen-Containing Heteroaryl Compounds and Methods of Use Thereof
Compounds and methods for treatment of cancer
Novel thienopyridine compounds, and methods of use thereof
Novel Thienopyridine Compounds, and Methods of Use Thereof
Cyanoisoquinoline Compounds and Methods of Use Thereof
Cyanoisoquinoline Compounds and Methods of Use Thereof
Cyanoisoquinoline Compounds and Methods of Use Thereof
Compounds and Methods for Treatment of Stroke
Pyrrolo- and Thiazolo-Pyridine Compounds, and Methods of Use Thereof
Compounds and Methods for Treatment of Chemotherapy-Induced Anemia
Oxazolopyridine and Isoxazolopyridine Derivatives for Use in the Treatment of Hif-Mediated Conditions
Isothiazole-Pyridine Derivatives as Modulators of Hif (Hypoxia Inducible Factor) Activity
Isothiazole-Pyridine Derivatives as Modulators of Hif (Hypoxia Inducible Factor) Activity
Chromene Derivatives and Use Thereof as Hif Hydroxylase Activity Inhibitors
Compounds and Methods for Their Use
Thiochromene Derivatives as Hif Hydroxylase Inhibitors
Thiochromene Derivatives as Hif Hydroxylase Inhibitors
Naphthyridine Derivatives as Inhibitors of Hypoxia Inducible Factor (Hif) Hydroxylase
Naphthyridine Derivatives as Inhibitors of Hypoxia Inducible Factor (Hif) Hydroxylase
Naphthyridine Derivatives as Inhibitors of Hypoxia Inducible Factor (Hif) Hydroxylase
4 -Hydroxy- Isoquinoline Compounds as Hif Hydroxylase Inhibitors
Process for Making Isoquinoline Compounds
Process for Making Isoquinoline Compounds
Crystalline Forms of {[1-Cyano-5-(4-Chlorophenoxy)-4-Hydroxy-Isoquinoline-3-Carbonyl]-Amino}-Acetic Acid
Crystalline Forms of a Prolyl Hydroxylase Inhibitor
Crystalline Forms of a Prolyl Hydroxylase Inhibitor
Crystalline Forms of a Prolyl Hydroxylase Inhibitor
Crystalline Forms of a Prolyl Hydroxylase Inhibitor
Crystalline Forms of a Prolyl Hydroxylase Inhibitor
Crystalline Forms of a Prolyl Hydroxylase Inhibitor
Crystalline Forms of a Prolyl Hydroxylase Inhibitor
Pharmaceutical Formulations of a Hif Hydroxylase Inhibitor
Connective Tissue Growth Factor Antibodies
Antibodies That Bind to a Portion of the Vwc Domain of Connective Tissue Growth Factor
Connective Tissue Growth Factor Antibodies
Diabetic Nephropathy Therapies
Treatments for Pancreatic Cancer Metastases
Treatments for Cancer
Methods of Treatment of Cardiovascular Disease Using Anti-Ctgf Agents
Methods for Treatment of Muscular Dystrophy
Treatment Method for Lung Remodeling Diseases
Therapeutic Method
Connective Tissue Growth Factor Antisense Oligonucleotides
Connective Tissue Growth Factor Antisense Oligonucleotides
Methods for Treating Idiopathic Pulmonary Fibrosis
Methods for Treating Idiopathic Pulmonary Fibrosis
Methods for Treating Idiopathic Pulmonary Fibrosis
Therapeutic Method for Pancreatic Cancer
Methods for Treatment of Motor Neuron Diseases
Methods for Improving Kidney Function
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 25, 2004
From: GUENZLER-PUKALL, VOLKMAR; KLAUS, STEPHEN J.; PAROBOK, INGRID LANGSETMO; SEELEY, TODD W.
To: FIBROGEN, INC.
Reel/Frame 014668/0521 →
Assignment of Assignor's Interest
Jul 22, 2004
From: FOURNEY, PATRICK D.; GUENZLER-PUKALL, VOLKMAR; KLAUS, STEPHEN J.; LIN, AL Y.
To: FIBROGEN, INC.
Reel/Frame 014889/0080 →
Assignment of Assignor's Interest
Sep 28, 2004
From: KLAUS, STEPHEN J.; MOLINEAUX, CHRISTOPHER J.; NEFF, THOMAS B.; GUENZLER-PUKALL, VOLKMAR
To: FIBROGEN, INC.
Reel/Frame 015194/0079 →
Assignment of Assignor's Interest
Oct 29, 2013
From: KLAUS, STEPHEN J.; MOLINEAUX, CHRISTOPHER J.; NEFF, THOMAS B.; GUENZLER-PUKALL, VOLKMAR
To: FIBROGEN, INC.
Reel/Frame 031500/0954 →
Change of Address
Oct 31, 2013
From: FIBROGEN, INC.
To: FIBROGEN, INC.
Reel/Frame 031526/0456 →
Assignment of Assignor's Interest
Jun 12, 2014
From: KLAUS, STEPHEN J.; MOLINEAUX, CHRISTOPHER J.; NEFF, THOMAS B.; GUENZIER-PUKALL, VOLKMAR
To: FIBROGEN, INC.
Reel/Frame 033180/0888 →
Assignment of Assignor's Interest
Dec 23, 2020
From: KLAUS, STEPHEN J.; LIN, AL Y.; NEFF, THOMAS B.; GUENZLER-PUKALL, VOLKMAR
To: FIBROGEN, INC.
Reel/Frame 054739/0624 →
Assignment of Assignor's Interest
Jan 5, 2021
From: KLAUS, STEPHEN J.; MOLINEAUX, CHRISTOPHER J.; NEFF, THOMAS B.; GUENZLER-PUKALL, VOLKMAR
To: FIBROGEN, INC.
Reel/Frame 054811/0752 →
Assignment of Assignor's Interest
Aug 5, 2021
From: KLAUS, STEPHEN J.; LIN, AL Y.; NEFF, THOMAS B.; WANG, QINGJIAN
To: FIBROGEN, INC.
Reel/Frame 057096/0579 →
Assignment of Assignor's Interest
Mar 7, 2022
From: BRANDAN, ENRIQUE; GONZALEZ, DAVID
To: FIBROGEN, INC.
Reel/Frame 059189/0526 →
Assignment of Assignor's Interest
Jul 29, 2022
From: PORTER, SETH; STAUFFER, JOHN L.
To: FIBROGEN, INC.
Reel/Frame 060668/0524 →
Assignment of Assignor's Interest
Aug 12, 2022
From: YU, KIN-HUNG (PEONY); KOUCHAKJI, ELIAS; ELMANKABADI, BASSEM; SEKAYAN, TRO
To: FIBROGEN, INC.
Reel/Frame 060794/0610 →
Assignment of Assignor's Interest
Nov 3, 2022
From: BROUSSEAU, DAVID T.; WALKINSHAW, GAIL; WITSCHI, CLAUDIA
To: FIBROGEN, INC.
Reel/Frame 061649/0149 →
Assignment of Assignor's Interest
Nov 3, 2022
From: OLSEN, DAVID
To: FIBROGEN, INC.
Reel/Frame 061649/0001 →
Assignment of Assignor's Interest
Nov 3, 2022
From: OLSEN, DAVID
To: FIBROGEN, INC.
Reel/Frame 061648/0940 →
Assignment of Assignor's Interest
Dec 20, 2022
From: LIN, AL Y.; NEFF, THOMAS B.; OLIVER, NOELYNN A.; USINGER, WILLIAM R.
To: FIBROGEN, INC.
Reel/Frame 062162/0545 →
Assignment of Assignor's Interest
May 9, 2023
From: CONCA, DAVID; FLIPPIN, LEE ALLEN; LEIGH, SCOTT DAVID; WITSCHI, CLAUDIA
To: FIBROGEN, INC.
Reel/Frame 063586/0535 →
Assignment of Assignor's Interest
Jun 30, 2023
From: ZHANG, QIAN; DONG, LING
To: HIFIBIO (HK) LIMITED
Reel/Frame 064132/0275 →
Assignment of Assignor's Interest
Jul 20, 2023
From: SPECIFICA LLC
To: FIBROGEN, INC.
Reel/Frame 064321/0114 →
Assignment of Assignor's Interest
Jul 20, 2023
From: POHL, TOM; FERRARA, FORTUNATO; BRADBURY, ANDREW
To: SPECIFICA LLC
Reel/Frame 064321/0087 →
Assignment of Assignor's Interest
Dec 22, 2023
From: ZHANG, ZUHUI; ZHOU, XIAOTI; AREND, MICHAEL P.; KJAERGAARD, CHRISTIAN HAUGE
To: FIBROGEN, INC.
Reel/Frame 065944/0349 →
Assignment of Assignor's Interest
Feb 1, 2024
From: HIFIBIO (HK) LIMITED
To: HIFIBIO, INC.
Reel/Frame 066331/0216 →
Assignment of Assignor's Interest
Feb 5, 2024
From: HIFIBIO (HK) LIMITED
To: HIFIBIO, INC.
Reel/Frame 066347/0278 →
Release of Security Interest
Sep 3, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: FIBROGEN, INC.
Reel/Frame 072785/0760 →
Change of Name
Feb 18, 2026
From: FIBROGEN, INC.
To: KYNTRA BIO, INC.
Reel/Frame 074923/0352 →